Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.43 |
| ▸ | PGK2 | P07205 | 1/20 | 0.43 |
| ▸ | PGD | P52209 | 4/20 | 0.41 |
| ▸ | MPI | P34949 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL888509 | 0.88 | PGK1 (0.48) | PGK1PGK2PGDMPILPAR1 | |
| SCHEMBL5297305 | 0.84 | PGD (0.45) | PGK1PGK2PGDMPILPAR1 | |
| SCHEMBL429247 | 0.84 | PGD (0.45) | PGK1PGK2PGDMPILPAR1 | |
| Glycerylphosphate SCHEMBL59773 | 0.83 | SMPD1 (0.37) | PGK1PGK2 | |
| SCHEMBL19462882 | 0.82 | PGK1 (0.43) | PGK1PGK2PGDMPILPAR1 | |
| SCHEMBL3447040 | 0.82 | PGK1 (0.43) | PGK1PGK2PGDMPILPAR1 | |
| SCHEMBL17338080 | 0.82 | PGK1 (0.43) | PGK1PGK2PGDMPILPAR1 | |
| Glycerylphosphate SCHEMBL9391484 | 0.80 | SMPD1 (0.35) | PGK1PGK2 | |
| Glycerylphosphate SCHEMBL14482182 | 0.80 | SMPD1 (0.35) | PGK1PGK2 | |
| Glycerylphosphate SCHEMBL2487169 | 0.80 | SMPD1 (0.35) | PGK1PGK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115094033-A | Method and device for separating fetal red blood cells | 广州鸿溪见杉科技有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-108367109-B | Method for extracorporeal lung support | 阿德维托斯有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-107319142-A | A kind of milch goat feed additive and preparation method thereof | 山东阳春羊奶乳业有限公司 | 2017-11-07 | — | — | CN | claimed |
| CN-105923716-A | Equipment for removing percolate chromium and cyanogen ions in sludge composting treatment in electroplating industry and removing method of equipment | 徐州工程学院 | 2016-09-07 | — | — | CN | claimed |
| CN-103250694-A | Composition and method for storing erythrocyte | UNIV CINCINNATI | 2013-08-21 | — | — | CN | claimed |
| CN-101166420-A | Compositions and methods for storing red blood cells | CINCINNATI UNIVERSITY (US) | 2008-04-23 | — | — | CN | claimed |
| US-20030075189-A1 | Protein based smoking cessation gel for application to a smoking article | GERAGHTY RICHARD JOHN (IE) | 2003-04-24 | — | — | US | claimed |
| WO-2023220387-A2 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| CN-115484932-A | Compositions and methods for targeted RNA delivery | 维乎医疗有限公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-115094033-A | Method and device for separating fetal red blood cells | 广州鸿溪见杉科技有限公司 | 2022-09-23 | — | — | CN | disclosed |
| CN-114317780-B | SNP molecular marker related to chicken prematurity and application | 华南农业大学 | 2022-09-09 | — | — | CN | disclosed |
| CN-114901258-A | Isolated mitochondria having a smaller size and lipid membrane-based vesicles encapsulating the isolated mitochondria | 卢卡科学株式会社 | 2022-08-12 | — | — | CN | disclosed |
| US-20220119821-A1 | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF ASPARTIC ACID AND B-ALANINE | UNITED STATES DEPARTMENT OF ENERGY | 2022-04-21 | — | — | US | disclosed |
| EP-0420930-A1 | METHOD OF SYNTHESIS AND NOVEL COMPOUNDS FOR PHARMACEUTICAL USES | LALEZARI, Iraj (US) | 1991-04-10 | — | — | EP | disclosed |
| EP-0358724-A4 | COMPOUND, COMPOSITION AND METHOD FOR THE REDUCTION OF LIPIDS THE MODIFICATION OF THE AFFINITY OF HEMOGLOBIN FOR OXYGEN AND THE PREVENTION OF PLATELET AGGREGATION. | LALEZARI IRAJ (US) | 1990-06-05 | — | — | EP | disclosed |
| US-4921997-A | Method of synthesis and novel compounds for pharmaceutical uses | MONTEFIORE MEDICAL CENTER (US) | 1990-05-01 | — | — | US | disclosed |
| EP-0358724-A1 | COMPOUND, COMPOSITION AND METHOD FOR THE REDUCTION OF LIPIDS THE MODIFICATION OF THE AFFINITY OF HEMOGLOBIN FOR OXYGEN AND THE PREVENTION OF PLATELET AGGREGATION | LALEZARI, Iraj (US) | 1990-03-21 | — | — | EP | disclosed |
| WO-1989012622-A1 | METHOD OF SYNTHESIS AND NOVEL COMPOUNDS FOR PHARMACEUTICAL USES | LALEZARI IRAJ (US) | 1989-12-28 | — | — | WO | disclosed |
| US-4849416-A | ANTIHYPOXIC AGENTS, HETEROCYCLIC SULFONAMIDO AZO COMPOUND | RORER PHARMACEUTICAL CORPORATION (US) | 1989-07-18 | — | — | US | disclosed |
| WO-1988010113-A1 | COMPOUND, COMPOSITION AND METHOD FOR THE REDUCTION OF LIPIDS THE MODIFICATION OF THE AFFINITY OF HEMOGLOBIN FOR OXYGEN AND THE PREVENTION OF PLATELET AGGREGATION | LALEZARI IRAJ (US) | 1988-12-29 | — | — | WO | disclosed |